Estrogen Activation of the Nuclear Orphan Receptor CAR (Constitutive Active Receptor) in Induction of the Mouse Cyp2b10 Gene
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The nuclear orphan receptor CAR (constitutively active receptor or constitutive androstane receptor) can be activated in response to xenochemical exposure, such as activation by phenobarbital of a response element called NR1 found in the CYP2B gene. Here various steroids were screened for potential endogenous chemicals that may activate CAR, using the NR1 enhancer and Cyp2b10 induction in transfected HepG2 cell and/or in mouse primary hepatocytes as the experimental criteria. 17beta-Estradiol and estrone activated NR1, whereas estriol, estetrol, estradiol sulfate, and the synthetic estrogen diethylstilbestrol did not. On the other hand, progesterone and androgens repressed NR1 activity in HepG2 cells, and the repressed NR1 activity was fully restored by estradiol. Moreover, estrogen treatment elicited nuclear accumulation of CAR in the mouse livers, as well as primary hepatocytes, and induced the endogenous Cyp2b10 gene. Ovariectomy did not affect either the basal or induced level of CAR in the nucleus of the female livers, while castration slightly increased the basal and greatly increased the induced levels in the liver nucleus of male mice. Thus, endogenous estrogen appears not to regulate CAR in female mice, whereas endogenous androgen may be the repressive factor in male mice. Estrogen at pharmacological levels is an effective activator of CAR in both female and male mice, suggesting a biological and/or toxicological role of this receptor in estrogen metabolism. In addition to mouse CAR, estrogens activated rat CAR, whereas human CAR did not respond well to the estrogens under the experimental conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that estrogen can both activate and inhibit CAR signaling depending on the ligand and its context,66,67 whereas androgen inhibits CAR transcriptional activity,68”
From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
A unified nomenclature system for the nuclear receptor superfamily
(1999) · Cell · doi:10.1016/s0092-8674(00)80726-6 · Cited by 1,208
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
Self-citationThe Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Self-citationPhenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene
Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., & Negishi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6318 · Cited by 549
Self-citationBaes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., & Moore, D. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1544 · Cited by 494
Androstane metabolites bind to and deactivate the nuclear receptor CAR-β
Forman, B. M., Tzameli, I., Choi, H.-S., Chen, J., Simha, D., Seol, W., Evans, R. M., & Moore, D. D. (1998) · Nature · doi:10.1038/26996 · Cited by 476
Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CAR
Choi, H.-S., Chung, M., Tzameli, I., Simha, D., Lee, Y.-K., Seol, W., & Moore, D. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23565 · Cited by 279
Gower, D. B., & Ruparelia, B. A. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1370167 · Cited by 175
Honkakoski, P., Moore, R., Washburn, K. A., & Negishi, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.597 · Cited by 162
Self-citation
Cited by
Items 101–185 of 185
Induction of Cytochrome P450 Enzymes
Williams, S. N., Dunham, E. E., & Bradfield, C. A. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_8 · Cited by 28
Characterization of the porcine constitutive androstane receptor (CAR) and its splice variants
Gray, M. A., Peacock, J., & Squires, E. J. (2009) · Xenobiotica · doi:10.3109/00498250903330348 · Cited by 26
Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach
Suter, L., Haiker, M., de Vera, M. C., & Albertini, S. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500207 · Cited by 26
Ueda, A., Kakizaki, S., Negishi, M., & Sueyoshi, T. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12086-x · Cited by 25
Self-citationJarukamjorn, K., Sakuma, T., & Nemoto, N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00989-9 · Cited by 24
Haduch, A., Wójcikowski, J., & Daniel, W. A. (2008) · PubMed · Cited by 23
Stokar, J., Gurt, I., Cohen‐Kfir, E., Yakubovsky, O., Hallak, N., Benyamini, H., Lishinsky-Fischer, N., Offir, N., Tam, J., & Dresner–Pollak, R. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101482 · Cited by 23
Modulation of Xenobiotic Receptors by Steroids
Banerjee, M., Robbins, D. F., & Chen, T. (2013) · Molecules · doi:10.3390/molecules18077389 · Cited by 22
Mineiro, R., Santos, C. R. A., Gonçalves, I., Lemos, M. C., Cavaco, J. E. B., & Quintela, T. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00957-1 · Cited by 22
Fujita, A., Furutama, D., Tanaka, T., Sakai, R., Kôyama, A., Hanafusa, T., Mitsuhashi, T., & Ohsawa, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03712-2 · Cited by 21
Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
Lukowicz, C., Ellero‐Simatos, S., Régnier, M., Oliviero, F., Lasserre, F., Polizzi, A., Montagner, A., Smati, S., Boudou, F., Lenfant, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56570-0 · Cited by 21
Kamata, R., Nakajima, D., & Shiraishi, F. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.09.014 · Cited by 20
Akiko, U. E. D. A., MATSUI, K., Yamamoto, Y., Pedersen, L. C., Sueyoshi, T., & Negishi, M. (2005) · Biochemical Journal · doi:10.1042/bj20041572 · Cited by 19
Self-citationOleaga, C., Ciudad, C. J., Izquierdo-Pulido, M., & Noé, V. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200507 · Cited by 18
Slitt, A. L., Cherrington, N. J., Fisher, C. D., Negishi, M., & Klaassen, C. D. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007542 · Cited by 18
Self-citationAbe, T., Shizu, R., Sasaki, T., Shimizu, Y., Hosaka, T., Kodama, S., Matsuzawa, A., & Yoshinari, K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258632 · Cited by 17
Self-citationLiu, Z., Li, L., Wu, H., Hu, J., Ma, J., Zhang, Q.-Y., & Ding, X. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061812 · Cited by 17
Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats
Lee, S. Y., Oh, S. J., Yun, K. U., Kim, H. M., Kim, B.-H., Lee, K., & Kim, S. K. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0730-1 · Cited by 17
Environmental xenoestrogens super-activate a variant murine ER beta in cholangiocytes
Meyer, S. K., Probert, P. M. E., Lakey, A. K., Leitch, A. C., Blake, L. I., Jowsey, P. A., Cooke, M. P., Blain, P. G., & Wright, M. C. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw234 · Cited by 15
Biological function and mode of action of nuclear xenobiotic receptors
Sonoda, J., & Evans, R. M. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111733 · Cited by 14
The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.
Haduch, A., Wójcikowski, J., & Daniel, W. A. (2007) · PubMed · Cited by 14
Impact of sex and pregnancy on hepatic CYP3A4 expression and activity in a humanized mouse model
Fashe, M. M., Miner, T. A., Collazo, V. L., Grieco, J. T., Fallon, J. K., Jackson, K. D., & Lee, C. R. (2024) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2024.100025 · Cited by 12
Alshabi, A. M., Shaik, I. H., Zhao, Y., Pillai, V. C., Caritis, S. N., & Venkataramanan, R. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03489-1 · Cited by 12
STUDY OF INFLUENCE OF ESTRADIOL ON THE ACTIVITY OF P-GLYCOPROTEIN IN VITRO
Erokhina, P. D., Abalenikhina, Y. V., Shchulkin, A. V., Chernykh, I. V., Kotlyarova, А. А., Pravkin, S. K., Slepnev, A. A., & Yakusheva, E. N. (2020) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj202083329-336 · Cited by 12
Pharmacokinetics and Pharmacodynamics: The Role of Sex and Gender
Franconi, F., Sanna, M., Straface, E., Chessa, R., & Rosano, G. M. C. (2011) · Springer eBooks · doi:10.1007/978-0-85729-832-4_12 · Cited by 11
Regulation of Drug Disposition Gene Expression in Pregnant Mice with Car Receptor Activation
Bright, A. S., Herrera‐Garcia, G., Moscovitz, J. E., You, D., Guo, G. L., & Aleksunes, L. M. (2016) · Nuclear Receptor Research · doi:10.11131/2016/101193 · Cited by 9
Kato, H., Yamaotsu, N., Iwazaki, N., Okamura, S., Kume, T., & Hirono, S. (2017) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.02.001 · Cited by 9
Mechanisms of altered hepatic drug disposition during pregnancy: small molecules
Fashe, M. M., Tiley, J. B., & Lee, C. R. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2470792 · Cited by 8
Sonkar, R., Ma, H., & Waxman, D. J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae057 · Cited by 8
Piccinato, C. D. A., Rosa, G. J. M., N′jai, A. U., Jefcoate, C. R. E., & Wiltbank, M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073552 · Cited by 8
The impact of pregnancy and associated hormones on the pharmacokinetics of Δ 9 -tetrahydrocannabinol
Authement, A. K., & Isoherranen, N. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2309213 · Cited by 7
Pascussi, J., Dvořák, Z., Gerbal‐Chaloin, S., Assénat, E., Drocourt, L., Maurel, P., & Vilarem, M. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_13 · Cited by 7
Dau, P. T., Sakai, H., Hirano, M., Ishibashi, H., Tanaka, Y., Kameda, K., Fujino, T., Kim, E., & Iwata, H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs288 · Cited by 7
Pan, S., Guo, Y., Yu, W., Zhang, J., Qiao, X., Li, L., Xu, P., & Zhai, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032602 · Cited by 6
The role of testosterone in the regulation of P-glycoprotein functioning
Shchulkin, A. V., Yakusheva, E. N., Chernykh, I. V., & Nikiforov, A. A. (2017) · Biology Bulletin · doi:10.1134/s1062359017050168 · Cited by 6
Shchulkin, A. V., Abalenikhina, Y. V., Slepnev, A. A., Rokunov, E. D., & Yakusheva, E. N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120600 · Cited by 6
Munoz, C., Schröder, K., Henes, B., Hubert, J., Leblond, S., Poigny, S., Reski, R., & Wandrey, F. (2024) · Applied Sciences · doi:10.3390/app14031274 · Cited by 5
Xenobiotic Receptors CAR and PXR
Klaassen, C. D., & Lü, H. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_11 · Cited by 5
Shchulkin, A. V., Chernykh, I. V., Popova, N. M., Slepnev, A. A., & Yakusheva, E. N. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206606444 · Cited by 5
CYP Gene Induction by Xenobiotics and Drugs
Daujat‐Chavanieu, M., Fabre, G., Vilarem, M., Pichard‐Garcia, L., Drocourt, L., Pascussi, J., Maurel, P., Klieber, S., Bourri√©, M., Gerbal‐Chaloin, S., et al. (2003) · Informa Healthcare eBooks · doi:10.1201/9781420028485.ch10 · Cited by 4
Characterization of the pig nuclear receptor CAR and its role in boar taint
Peacock, J. (2005) · The Atrium (University of Guelph) · Cited by 4
HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis
Dender, C. V., Timmermans, S., Roes, M., Hellemans, M., Moens, E., Nuyttens, L., Claes, M., Roman, B. I., Bosscher, K. D., Vandewalle, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625104 · Cited by 3
Albetawi, S. N., Meakin, A. S., Lien, Y., Wiese, M. D., Simmons, R. A., & Morrison, J. L. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117786 · Cited by 3
Cytochrome P450 in Laboratory Animal Species
Spatzenegger, M., Born, S. L., & Halpert, J. R. (2003) · Informa Healthcare eBooks · doi:10.1201/9781420028485.ch6 · Cited by 3
Factors Influencing Regulation of CYP2B Expression
Udomsuk, L., & Jarukamjorn, K. (2009) · Thai Pharmaceutical and Health Science Journal - วารสารไทยเภสัชศาสตร์และวิทยาการสุขภาพ · Cited by 3
Lo, R. (2014) · TSpace (University of Toronto) · Cited by 2
Estrogen associations with human pregnancy related increases in cytochrome P450 3A activity
Fashe, M. M., Lee, J., Grieco, J. T., Fallon, J. K., Mulrenin, I. R., Gower, M. N., Jackson, K. D., Boggess, K., & Lee, C. R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1702419 · Cited by 2
Jhajra, S., Singh, S., Holm, K. A., Faqi, A. S., & Sahi, J. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm045 · Cited by 2
Influence of Sex Hormones on the ABCG2 Transport Protein in Caco-2 Cells
Slepnev, A. A., Abalenikhina, Y. V., Popova, N. M., Shchulkin, A. V., & Yakusheva, E. N. (2023) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.31857/s0233475523050109 · Cited by 2
Lukowicz, C. (2018) · theses.fr (ABES) · doi:10.70675/881e84fazadd6z4a73zafdfzcf838fd002b4 · Cited by 1
Signaling Pathways in Liver Diseases: PXR and CAR
Stedman, C. A. M., Downes, M., & Liddle, C. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_22 · Cited by 1
Moscovitz, J. E., Gorczyca, L., & Aleksunes, L. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802949-7.00009-2 · Cited by 1
Mechanisms of Testosterone Effects on the Transport Protein P-Glycoprotein
Slepnev, A. A., Shchulkin, A. V., Abalenikhina, Y. V., Popova, N. M., Chernykh, I. V., & Yakusheva, E. N. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022050210 · Cited by 1
Lukowicz, C., Ellero‐Simatos, S., Régnier, M., Oliviero, F., Lasserre, F., Polizzi, A., Montagner, A., Smati, S., Boudou, F., Lenfant, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61226-5 · Cited by 1
Zhou, W., Chembazhi, U. V., Huang, J., Bangru, S., Dean, A. E., Asokakumar, A., Kalsotra, A., Rudnick, D. A., & Anakk, S. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101858
Sexual dimorphism in the liver
Jain, A., & Monga, S. P. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01244-2
Barretto, S. A. (2019) · theses.fr (ABES) · doi:10.70675/fa5edab1z50c0z4b21z96d3z01d01036532a
Yamamoto, M., Matsunaga, H., Yamada, H., & Oguri, K. (2001) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.16.12
Bajnokova, M., Laštůvková, H., Ambrož, M., Hroch, M., Štefela, A., Hricová, J., Smutná, L., Schreiberová, J., Kučera, O., Manna, D. F., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.027
XENOSENSOR REGULATION OF ENZYMES AND TRANSPORTERS IN DRUG EXPOSURE AND DISEASE
Merrell, M. D. (2011) · UA Campus Repository (The University of Arizona)
DEVELOPMENTAL REGULATION OF THE DRUG-PROCESSING GENOME IN MOUSE LIVER
Cui, Y. J. (2010) · KU ScholarWorks (The University of Kansas)
Convergence of Multiple Nuclear Receptor Signaling
Webb, S. J., Falkner, K. C., Geoghegan, T. E., & Prough, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00213-x
Chan, G. N. Y. (2014) · TSpace (University of Toronto)
New Insights into Genetic Variation and Cancer
Siemes, C. (2007) · EUR Research Repository (Erasmus University Rotterdam)
THE ROLE OF CAR AND PXR IN TOXICANT SENSITIVITY
Mota, L. C. (2010) · TigerPrints (Clemson University)
Taylor, R. E., & Aleksunes, L. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29289-7.00026-6
Effect of Sex Hormones on the ABCG2 Transport Protein in Caco-2 Cells
Slepnev, A. A., Abalenikhina, Y. V., Popova, N. M., Shchulkin, A. V., & Yakusheva, E. N. (2023) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747823050100
Teaching an old drug new tricks: re-profiling of nevirapine as an hdl modulator
Marinho, A. T. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Rôle dépendant du sexe du récepteur constitutif aux androstanes CAR dans le métabolisme hépatique
Huillet, M. (2024) · theses.fr (ABES) · doi:10.70675/540eb301z7e1az46b2z8bc9z8e0347fb266a
Porcine model of xenobiotic metabolism
De, A. K. (2016) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Huillet, M., Martin, C. M. P., Magne, G., Lasserre, F., Bruse, J., Alquier‐Bacquie, V., Polizzi, A., Rives, C., Perrier, P., Poirier-Jaouen, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.08.757558
CYP-mediated drug metabolism from fetal life to adulthood
Albetawi, S. N., Meakin, A. S., Wiese, M. D., & Morrison, J. L. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109729
Hypertonicity Regulation of Cytochrome P450 CYP3A
I-Chyang, A. C. (2012) · TSpace (University of Toronto)
Deo, A. K. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0068293
Sukupuolen vaikutus lääkkeiden farmakokinetiikkaan ja lääkevasteeseen
Mantila, E. (2024) · UTUPub (University of Turku)
Ise, R., Kito, G., & Uno, Y. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-nt-147
Choi, S.-Y. (2012) · Figshare
Trimethylpentane (all isomers) [MAK Value Documentation, 2006]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Greim, H. (2014) · Wiley eBooks · doi:10.1002/3527600418.mb2922248ise4114
Trimethylpentan (alle Isomeren) [MAK Value Documentation in German language, 2006]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Greim, H. (2012) · Wiley eBooks · doi:10.1002/3527600418.mb2922248ismd0041
Trocho Muñoz, M. C. (2003) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
異物応答性核内受容体CARによるCYP2B6発現誘導に関するin silico予測研究
Kato, H. (2017) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Kawamoto, T., Kakizaki, S., Yoshinari, K., & Negishi, M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Negishi, Masahiko
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-11
- Volume
- 14
- Issue
- 11
- Pages
- 1897-1905
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2149182910
- Cited by
- 168
- References
- 17
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 4 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 11 · 2012: 14
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- constitutive androstane receptor, Cyp2b10, estradiol, estrone, sex differences, ovariectomy, castration, estrogen metabolism
- MeSH terms
- Cytochrome P450 Family 2, Constitutive Androstane Receptor, Androgens, Animals, Aryl Hydrocarbon Hydroxylases, Cytochrome P-450 Enzyme System, Enhancer Elements, Genetic, Estrogens, Female, Humans, Liver, Male, Mice, Inbred ICR, Ovariectomy, Progesterone, Species Specificity, Steroid Hydroxylases, Steroids, Transcription Factors, Transfection, Receptors, Cytoplasmic and Nuclear, Hepatocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.